Protein Kinase N Promotes Stress-Induced Cardiac Dysfunction Through Phosphorylation of Myocardin-Related Transcription Factor A and Disruption of Its Interaction With Actin
Authors: Sakaguchi Teruhiro , Takefuji Mikito , Wettschureck Nina , Hamaguchi Tomonari , Amano Mutsuki , Kato Katsuhiro , Tsuda Takuma , Eguchi Shunsuke , Ishihama Sohta , Mori Yu , Yura Yoshimitsu , Yoshida Tatsuya , Unno Kazumasa , Okumura Takahiro , Ishii Hideki , Shimizu Yuuki , Bando Yasuko K. , Ohashi Koji , Ouchi Noriyuki , Enomoto Atsushi , Offermanns Stefan , Kaibuchi Kozo , Murohara Toyoaki 
Published: September 2019

Background:

Heart failure is a complex syndrome that results from structural or functional impairment of ventricular filling or blood ejection. Protein phosphorylation is a major and essential intracellular mechanism that mediates various cellular processes in cardiomyocytes in response to extracellular and intracellular signals. The RHOA-associated protein kinase (ROCK/Rho-kinase), an effector regulated by the small GTPase RHOA, causes pathological phosphorylation of proteins, resulting in cardiovascular diseases. RHOA also activates protein kinase N (PKN); however, the role of PKN in cardiovascular diseases remains unclear.

Methods:

To explore the role of PKNs in heart failure, we generated tamoxifen-inducible, cardiomyocyte-specific PKN1- and PKN2-knockout mice by intercrossing the αMHC-CreERT2 line with
Pkn1
flox/flox
and
Pkn2
flox/flox
mice and applied a mouse model of transverse aortic constriction– and angiotensin II–induced heart failure. To identify a novel substrate of PKNs, we incubated GST-tagged myocardin-related transcription factor A (MRTFA) with recombinant GST-PKN-catalytic domain or GST-ROCK-catalytic domain in the presence of radiolabeled ATP and detected radioactive GST-MRTFA as phosphorylated MRTFA.

Results:

We demonstrated that RHOA activates 2 members of the PKN family of proteins, PKN1 and PKN2, in cardiomyocytes of mice with cardiac dysfunction. Cardiomyocyte-specific deletion of the genes encoding
Pkn1
and
Pkn2
(cmc-PKN1/2 DKO) did not affect basal heart function but protected mice from pressure overload– and angiotensin II–induced cardiac dysfunction. Furthermore, we identified MRTFA as a novel substrate of PKN1 and PKN2 and found that MRTFA phosphorylation by PKN was considerably more effective than that by ROCK in vitro. We confirmed that endogenous MRTFA phosphorylation in the heart was induced by pressure overload– and angiotensin II–induced cardiac dysfunction in wild-type mice, whereas cmc-PKN1/2 DKO mice suppressed transverse aortic constriction– and angiotensin II–induced phosphorylation of MRTFA. Although RHOA-mediated actin polymerization accelerated MRTFA-induced gene transcription, PKN1 and PKN2 inhibited the interaction of MRTFA with globular actin by phosphorylating MRTFA, causing increased serum response factor–mediated expression of cardiac hypertrophy– and fibrosis-associated genes.

Conclusions:

Our results indicate that PKN1 and PKN2 activation causes cardiac dysfunction and is involved in the transition to heart failure, thus providing unique targets for therapeutic intervention for heart failure.